Auburn Pharmaceutical Company Sustainability Profile
Auburn Pharmaceutical Company, often referred to simply as Auburn Pharma, is a prominent player in the pharmaceutical industry, headquartered in the United States. Established in 2005, the company has made significant strides in developing innovative healthcare solutions, particularly in the fields of pain management and anaesthesia. With a strong operational presence across North America and Europe, Auburn Pharma is renowned for its unique formulations and commitment to quality. The company’s core products include a range of injectable medications that stand out for their efficacy and safety profiles. Auburn Pharmaceutical Company has achieved notable recognition within the industry, positioning itself as a trusted partner for healthcare providers. Its dedication to research and development continues to drive advancements in patient care, solidifying its reputation as a leader in pharmaceutical innovation.
DitchCarbon Score
How does Auburn Pharmaceutical Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Auburn Pharmaceutical Company's score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Auburn Pharmaceutical Company's reported carbon emissions
Auburn Pharmaceutical Company, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Auburn Pharmaceutical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the broader context of the pharmaceutical industry, many companies are increasingly adopting science-based targets and sustainability practices to mitigate climate impact. However, without specific emissions data or commitments, Auburn Pharmaceutical's position in this evolving landscape remains unclear.
How Carbon Intensive is Auburn Pharmaceutical Company's Industry?
How Carbon Intensive is Auburn Pharmaceutical Company's Location?
Auburn Pharmaceutical Company's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Auburn Pharmaceutical Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
